primary antibodies against myh7 (Developmental Studies Hybridoma Bank)
Developmental Studies Hybridoma Bank is a verified supplier 
Developmental Studies Hybridoma Bank manufactures this product 
94
Structured Review
Developmental Studies Hybridoma Bank
primary antibodies against myh7
Primary Antibodies Against Myh7, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/laminin+d18/anti-laminin/bio_rxiv__64898__2026__04__20__719776-217-39-45
Average 94 stars, based on 74 article reviews
Primary Antibodies Against Myh7, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/laminin+d18/anti-laminin/bio_rxiv__64898__2026__04__20__719776-217-39-45
Average 94 stars, based on 74 article reviews
primary antibodies against myh7 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Incubation:Article Title: Transcatheter Intra‐Arterial Delivery of a Platelet‐Derived Extracellular Vesicle‐Enriched Preparation for Attenuating Skeletal Muscle Ischaemia‐Reperfusion Injury in a Rodent Forelimb Model Article Snippet: Next, 7‐μm thick frozen sections were cut using a standard cryostat (Leica CM1850, Leica Biosystems, IL) and loaded onto glass microscope slides (Fisherbrand Superfrost Plus Microscope Slides, Fisher Scientific, MA). .. Frozen sections were then incubated with Bioprocessing:Article Title: Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men Article Snippet: Serial 5‐μm‐thick VL muscle cross‐sections were cut at −20 °C using a cryostat (Leica, CM 1850, Germany), mounted on glass slides, and air dried at room temperature. .. Determination of fibre‐type‐specific cross‐sectional area was performed using monoclonal antibodies against slow (BA‐F8) and fast myosin (SC‐71) and |